Virpax Pharmaceuticals to conduct reverse stock split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2025
0mins
Source: SeekingAlpha
Reverse Stock Split Announcement: Virpax Pharmaceuticals will implement a 1-for-25 reverse stock split of its common stock to comply with the minimum bid price rule.
Additional Information: The announcement includes references to Seeking Alpha’s Quant Rating and historical earnings data for the company.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
